Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

1,072 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,072 results

Early research (Phase 1)Ended earlyNCT02058017
What this trial is testing

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
National University Hospital, Singapore 9
Not applicableLooking for participantsNCT07618078
What this trial is testing

Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 900
Not applicableStudy completedNCT02584790
What this trial is testing

NBI to Detect Post-RT Mucosal Residual NPC

Who this might be right for
Nasopharyngeal Carcinoma
Pamela Youde Nethersole Eastern Hospital 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT06223568
What this trial is testing

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckOropharynxHuman Papillomavirus Viruses+2 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Looking for participantsNCT06802835
What this trial is testing

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Recurrent Nasopharynx CarcinomaMetastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 148
Not applicableLooking for participantsNCT07548268
What this trial is testing

Transoral and Cervical Ultrasound of Patients With Suspected Oropharyngeal Cancer

Who this might be right for
Oropharyngeal CarcinomaUltrasound
Tobias Todsen 180
Testing effectiveness (Phase 2)Study completedNCT03558191
What this trial is testing

SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 156
Not applicableUnknownNCT04810936
What this trial is testing

Early Nutritional Intervention in NPC Patients Undergoing Concurrent Chemoradiotherapy

Who this might be right for
MalnutritionNasopharyngeal Carcinoma
Guangdong Provincial People's Hospital 272
Large-scale testing (Phase 3)Study completedNCT00370890
What this trial is testing

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Who this might be right for
Nasopharyngeal Cancer
Chinese University of Hong Kong 104
Not applicableUnknownNCT04419324
What this trial is testing

To Evaluate Transoral Flexible Endoscope With Narrow Band Imaging in Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Carcinoma
Chinese University of Hong Kong 40
Testing effectiveness (Phase 2)Ended earlyNCT00484601
What this trial is testing

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Who this might be right for
Refractory Nasopharyngeal Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT00827164
What this trial is testing

Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer

Who this might be right for
Head and Neck CancerPharyngeal CancerLaryngeal Cancer
University of Alabama at Birmingham 29
Not applicableLooking for participantsNCT04085900
What this trial is testing

Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City

Who this might be right for
Nasopharyngeal Carcinoma
Zhongshan People's Hospital, Guangdong, China 40,000
Not applicableLooking for participantsNCT06533267
What this trial is testing

Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal CarcinomaIntensity Modulated RadiotherapySurgery
Sun Yat-sen University 442
Testing effectiveness (Phase 2)Ended earlyNCT01403259
What this trial is testing

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 16
Testing effectiveness (Phase 2)UnknownNCT04992988
What this trial is testing

Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial

Who this might be right for
Nasopharyngeal CarcinomaToripalimabRecurrent Nasopharyngeal Squamous Cell Carcinoma
Cancer Hospital of Guangxi Medical University 40
Large-scale testing (Phase 3)UnknownNCT01872962
What this trial is testing

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 480
Not applicableStudy completedNCT04189003
What this trial is testing

Molecular Signatures of HPV+ ORL Cancers (OROPAP)

Who this might be right for
Oropharyngeal CancerHuman Papillomavirus-Related Carcinoma
Assistance Publique - Hôpitaux de Paris 66
Testing effectiveness (Phase 2)Temporarily pausedNCT05198479
What this trial is testing

Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in

Who this might be right for
Metastatic Nasopharyngeal Cancer
National Cancer Centre, Singapore 25
Early research (Phase 1)UnknownNCT01341834
What this trial is testing

Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

Who this might be right for
Nasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid Tumour
National Cancer Centre, Singapore 49
Next Page